Impact of serum bilirubin on human diseases

Pediatrics

Volumn 115, Issue 5, 2005, Pages 1411-1412

  Vítek, Libor ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN D; BILIRUBIN; ESTROGEN; PORPHYRIN; ANTIOXIDANT; BIOLOGICAL MARKER;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; ATOPIC DERMATITIS; BILIRUBIN BLOOD LEVEL; CANCER RISK; CARCINOGENESIS; CEREBROSPINAL FLUID EXAMINATION; COLON CANCER; COLORECTAL CANCER; CONGESTIVE HEART FAILURE; GILBERT DISEASE; HUMAN; HYPERBILIRUBINEMIA; ISCHEMIC HEART DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MENTAL STRESS; NOTE; OXIDATION KINETICS; OXIDATIVE STRESS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; URINARY EXCRETION; BLOOD; CARDIOVASCULAR DISEASE; METABOLISM; NEOPLASM; PHYSIOLOGY;

ANTIOXIDANTS; BILIRUBIN; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; NEOPLASMS; OXIDATIVE STRESS;

EID: 25144435988     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-1796     Document Type: Note

References (35)

1. Sedlak TW, Snyder SH. Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics. 2004;113:1776-1782
2. Vitek L, Jirsa M, Brodanova M, et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis. 2002;160:449-456
3. Shimomura H, Ogawa H, Takazoe K, et al. Comparison of urinary biopyrrin levels in acute myocardial infarction (after reperfusion therapy) versus stable angina pectoris and their usefulness in predicting subsequent cardiac events. Am J Cardiol. 2002;90:108-111
4. Morita Y, Takahashi H, Kamihata H, Yamamoto Y, Hara K, Iwasaka T. Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases after spasm provocation tests in patients with coronary spastic angina. Int J Cardiol. 2001;80:243-250
5. Hokamaki J, Kawano H, Yoshimura M, et al. Urinary biopyrrins levels are elevated in relation to severity of heart failure. J Am Coll Cardiol. 2004;43:1880-1885
6. Tsukahara H, Haruta T, Todoroki Y, et al. Oxidant and antioxidant activities in childhood meningitis. Life Sci. 2002;71:2797-2806
7. Kozaki N, Shimizu S, Chijiiwa K, et al. Bilirubin as an anti-oxidant for surgical stress: a preliminary report of bilirubin oxidative metabolites. HPB Surg. 1999;11:241-248
8. Tsujinaka T, Fujita J, Morimoto T, et al. Increased urinary excretion of bilirubin metabolites in association with hyperbilirubinemia after esophagectomy. Surg Today. 1998;28:1119-1123
9. Yamaguchi T, Shioji I, Sugimoto A, Yamaoka M. Psychological stress increases bilirubin metabolites in human urine. Biochem Biophys Res Commun. 2002;293:517-520
10. Yoshida R, Ogawa Y, Shioji I, et al. Urinary 8-oxo-7, 8-dihydro-2′-deoxyguanosine and biopyrrins levels among construction workers with asbestos exposure history. Ind Health. 2001;39:186-188
11. Kimpara T, Takeda A, Yamaguchi T, et al. Increased bilirubins and their derivatives in cerebrospinal fluid in Alzheimer's disease. Neurobiol Aging. 2000;21:551-554
12. Vitek L, Kraslova I, Muchova L, Dudkova L, Novotny L, Yamaguchi T. Urinary excretion of oxidative metabolites of bilirubin in subjects with Gilbert syndrome [abstract]. FASEB J. 2004;18:A1189
13. Wei M, Schwertner HA, Gibbons LW, Zheng Q, Mitchell TL. Low fasting serum bilirubin as a predictor of cancer mortality in men [abstract]. Hepatology. 2000;32:427A
14. Ko WF, Helzlsouer KJ, Comstock GW. Serum albumin, bilirubin, and uric acid and the anatomic site-specific incidence of colon cancer. J Natl Cancer Inst. 1994;86:1874-1875
15. Zucker SD, Qin XF, Yu F, Goessling W. Inhibition of breast cancer cell proliferation by unconjugated bilirubin is associated with enhanced expression of apolipoprotein D and increased nuclear translocation of transcription factor NF-kappa B [abstract]. Hepatology. 1999;30:498A
16. Goessling W, Zucker SD. Role of apolipoprotein D in the transport of bilirubin in plasma. Am J Physiol Gastrointest Liver Physiol. 2000;279:G356-G365
17. Sanchez LM, Vizoso F, Diez-Itza I, Lopez-Otin C. Identification of the major protein components in breast secretions from women with benign and malignant breast diseases. Cancer Res. 1992;52:95-100
18. Rodriguez JC, Diaz M, Gonzalez LO, et al. Apolipoprotein D expression in benign and malignant prostate tissues. Int J Surg Investig. 2000;2:319-326
19. Keshavan P, Schwemberger SJ, Smith DL, Babcock GF, Zucker SD. Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization. Int J Cancer. 2004;112:433-445
20. Zucker SD, Horn PS, Sherman KE. Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology. 2004;40:827-835
21. Guillemette C, Millikan RC, Newman B, Housman DE. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res. 2000;60:950-956
22. Adegoke OJ, Shu XO, Gao YT, et al. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer. Breast Cancer Res Treat. 2004;85:239-245
23. Guillemette C, De Vivo I, Hankinson SE, et al. Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels. Cancer Epidemiol Biomarkers Prev. 2001;10:711-714
24. Nicholl P, Mikhailidis D, Hamilton G, Spyropolous LK, Winder AF. Bilirubin and peripheral vascular disease [abstract]. Br J Surg. 1995;82:1561-1562
25. Krijgsman B, Papadakis JA, Ganotakis ES, Mikhailidis DP, Hamilton G. The effect of peripheral vascular disease on the serum levels of natural anti-oxidants: bilirubin and albumin. Int Angiol. 2002;21:44-52
26. Cerne D, Ledinski G, Kager G, Greilberger J, Wang XS, Jurgens G. Comparison of laboratory parameters as risk factors for the presence and the extent of coronary or carotid atherosclerosis: the significance of apolipoprotein B to apolipoprotein all ratio. Clin Chem Lab Med. 2000;38:529-538
27. Kangas E, Teittinen K, Vilkko P, Utriainen S. Bilirubin and peripheral vascular disease. Br J Surg. 1999;86(5):713
28. Krijgsman B, Mikhailides DP, Winder AF, Hamilton G. Bilirubin and peripheral vascular disease [letter]. Br J Surg. 2000;87:251-252
29. Vitek L, Novotny L, Spacil J, Sperl M, Holaj R. The role of elevated serum bilirubin levels on carotid atherosclerosis [abstract]. Hepatology. 2003;38:383A
30. Ko GT, Chan JC, Woo J, et al. Serum bilirubin and cardiovascular risk factors in a Chinese population. J Cardiovasc Risk. 1996;3:459-463
31. Papadakis JA, Ganotakis ES, Jagroop IA, Mikhailidis DP, Winder AF. Effect of hypertension and its treatment on lipid, lipoprotein(a), fibrinogen, and bilirubin levels in patients referred for dyslipidemia. Am J Hypertens. 1999;12:673-681
32. Vitek L, Novotny L, Muchova L, Tesar V, Schwertner H. Decreased levels of serum bilirubin as a risk factor in lupus nephropathy. J Am Soc Nephrol. 2003;14:381A-382A
33. Ohrui T, Yasuda H, Yamaya M, Matsui T, Sasaki H. Transient relief of asthma symptoms during jaundice: a possible beneficial role of bilirubin. Tohoku J Exp Med. 2003;199:193-196
34. Ohrui T, Higuchi M, Kanda A, Matsui T, Sato E, Sasaki H. A patient with exacerbation of idiopathic pulmonary fibrosis which was resolved probably due to the coexisting hyperbilirubinemia? Tohoku J Exp Med. 2001;193:245-249
35. Oren DA, Desan PH, Boutros N, Anand A, Charney DS. Effects of light on low nocturnal bilirubin in winter depression: a preliminary report. Biol Psychiatry. 2002;51:422-425